CSF2 and rheumatoid arthritis: In contrast, in patients with rheumatoid arthritis (RA), GM-CSF is overexpressed as an inflammatory cytokine, and a monoclonal antibody against GM-CSF receptor is being investigated as novel therapeutic agents [2].